(Q44052454)

29 November 2017

Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats (English)

1 reference

29 November 2017

Leyre Urigüen

5

0 references

author name string

Eva M Romero

1

1 reference

29 November 2017

Beatriz Fernández

2

1 reference

29 November 2017

Onintza Sagredo

3

1 reference

29 November 2017

Nuria Gomez

4

1 reference

29 November 2017

Carmen Guaza

6

1 reference

29 November 2017

Rosario De Miguel

7

1 reference

29 November 2017

Jose Antonio Ramos

8

1 reference

29 November 2017

M Paz Viveros

9

1 reference

29 November 2017

1 June 2002

1 reference

29 November 2017

8

1 reference

Developmental Brain Research

inferred from page(s)

published in

1 reference

29 November 2017

136

1 reference

29 November 2017

85-92

1 reference

29 November 2017

2

1 reference

The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats.

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Behavioral effects of cannabinoid agents in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Naltrindole administration during the preweanling period and manipulation affect adrenocortical reactivity in young rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to mu and kappa agonists in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

The endogenous cannabinoid system and brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Role of endocannabinoids in brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Developmental aspects of anandamide: ontogeny of response and prenatal exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Cannabinoids as potential new analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Low-level lead exposure alters morphine antinociception in neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Pharmacological and biochemical interactions between opioids and cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Cannabinoid modulation of rat pup ultrasonic vocalizations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Cannabinoid receptors in developing rats: detection of mRNA and receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Motor disturbances induced by an acute dose of delta 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Atypical location of cannabinoid receptors in white matter areas during rat brain development.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Activational role of cannabinoids on movement

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Synergistic interactions of endogenous opioids and cannabinoid systems

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2802%2900306-1

7 January 2021

10.1016/S0165-3806(02)00306-1

Identifiers

DOI

1 reference

29 November 2017

1 reference